A drug company has filed a multi-million estafa case with the Makati City prosecutors office against 19 officials of pharmaceutical and laboratory firms for their failure to pay their financial obligations.
Charged with violations of Article 315 of the Revised Penal Code were directors and key officers of Pascual Laboratories, Inc., ADP Pharma, Inc. and Pascual Pharma Corporation.
The case stemmed from a complaint filed by Integra Pharma Corporation represented by Ronald Allan Cruz.
Integra accused the respondents led by Abraham Pascual, Martin Pascual, Manolo Escueta and Bodgit Gomez of non-payment of P48 million for the purchase and asset acquisition of the company in 2008.
Apart from the P48 million, Integra is seeking P200 million in damages from the three companies for the alleged illegal utilization of products licenses previously assigned to Integra, now Medcore.
“The aforementioned collective acts and omissions of the respondents amount to violation of Article 318 of the Revised Penal Code or estafa or swindling or other deceits,” Cruz stated in his complaint affidavit dated February 8, 2021.
The complaint remains with the Makati City Prosecutor’s Office due to re-assignment and the delay brought about by the stricter lockdowns imposed by the government to stop the spread of the coronavirus disease.
